CurePSP

As Day 2 of #Neuro2024 concludes, we extend our gratitude to all our speakers and attendees for their invaluable contributions. The gathering and sharing of research is crucial for advancing our understanding of progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD). Thank you for being an integral part of this collaborative journey. We anticipate the continuation of these important discussions. Check out some highlights from today’s sessions! #CurePSP #UHN #PSP #CBD #Neuro #Neuroscience #Research

Here’s a glimpse of some of our distinguished speakers of Day 2 at #Neuro2024! 🌟 Their knowledge and insights have enriched our discussions and furthered our understanding of PSP and CBD. Today's presentations included topics such as a trailblazing conceptual framework to understand the pathogenesis of PSP, wearable remote monitoring technology for tracking PSP symptoms and beyond tau: insights from clinical, neuropathological and genetic studies. Thank you to all our speakers for their valuable contributions! Speakers: Gabor G. Kovacs, University of Toronto and University Health Network, Toronto, Canada  Ashkan Vaziri, BioSensics, Newton, Massachusetts, USA  John Crary, Friedman Brain Institute, Ronald M. Loeb Center for Alzheimer’s Disease, Icahn School of Medicine at Mount Sinai, New York, New York, USA #CurePSP #UHN #Research #Neuro #Neuroscience

Welcome to Day 2 of Neuro2024: The PSP and CBD International Research Symposium! After a successful first day of engaging discussions and groundbreaking presentations, we’re excited to dive even deeper today. Hosted by CurePSP and the Rossy PSP Centre at the University Health Network at the Krembil Brain Institute, part of the University of Toronto, this symposium continues to bring the brightest minds in neuroscience together at the Omni King Edward Hotel in Toronto, Ontario. Day 2 will feature advanced insights, in-depth research, and collaborative sessions that aim to drive forward our understanding of PSP and CBD. It’s another opportunity to connect, share and inspire innovation in the fight against these diseases. Join the conversation by using the hashtag #Neuro2024 on X! #CurePSP #UHN #PSP #CBD #Neuroscience #Research

Here are just a few of our esteemed speakers from Day 1 of #Neuro2024! 🔬 The invaluable insights and expertise of our speakers have significantly advanced our understanding of progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD). Today's presentations will address critical subjects, including updates on the DescribePSP and ProPSP initiatives, the CurePSP Genetics Program, and an exploration of endemic Parkinsonism, focusing on clusters and associated risk factors. We extend our gratitude to all speakers for their impactful contributions. Speakers: Günter Höglinger, LMU Klinikum München, Munich, Germany, Munich, Germany  Anne-Marie Wills, Massachusetts General Hospital and Harvard Medical School, Cambridge, Massachusetts, USA  Petr Kanovsky, Palacký University Olomouc, Olomouc, Czech Republic #CurePSP #UHN #Research #Neuro #Neuroscience

Thank you to all our sponsors of Neuro2024: The PSP and CBD International Research Symposium! Your support is invaluable in advancing research and fostering collaboration in the field of PSP and CBD. Thank you for your commitment and partnership! GemVax & KAEL The Rainwater Charitable Foundation Life Molecular Imaging The Association for Frontotemporal Degeneration (AFTD) Ferrer #CurePSP #UHN #Neuro2024 #Research #Neuro #Neuroscience

Welcome to Day 1 of Neuro2024: The PSP and CBD International Research Symposium! Hosted by CurePSP and the Rossy PSP Centre at the University Health Network at the Krembil Brain Institute, part of the University of Toronto, this two-day event brings together leading neuroscientists from around the globe at the Omni King Edward Hotel in Toronto, Ontario. Today kicks off a series of expert discussions and presentations highlighting breakthrough discoveries and advancements in the field. This symposium is an opportunity to foster collaboration, inspire innovation and drive progress in understanding and treating PSP and CBD. We look forward to insightful sessions and productive conversations and invite you to join the discussion by using the hashtag #Neuro2024 on X! Let’s shape the future of neuroscience together! #CurePSP #UHN #PSP #CBD #Neuroscience #Research

CurePSP is thrilled to have Ferrer as a sponsor for #Neuro2024! After recently announcing the inclusion of the first participant for PROSPER, their Phase 2 trial for a PSP therapeutic, Ferrer hopes to continue research momentum in studies that target tau to slow disease progression. As the networking breaks sponsor, Ferrer will be promoting collaboration amongst experts that accelerates the speed at which landmark trials like this will occur! Learn more about our partners at Neuro2024 here: https://lnkd.in/ePGxJqm6    #PSP #CBD #MSA #Research #Discovery #Ferrer

Rep. Jennifer Wexton delivering what is believed to be the first speech on the House floor ever given via a voice cloned by AI was a landmark moment not just for herself, but for the entire CurePSP community. We realize the profound impact that this technology can have for those affected by these diseases and are monitoring the latest advances in augmentative and alternative communication (AAC) devices and technology. Learn more about the options that exist for your unique situation as CurePSP remains committed to being at the forefront of these exciting discoveries: https://lnkd.in/dEYGb9PZ #PSP #CBD #MSA #BecauseHopeMatters #AI #Discovery #AAC #Voicebanking

CurePSP is excited to welcome GemVax & KAEL as a signature sponsor for #Neuro2024! GemVax, a leading biotech company from Korea, gained attention in 2017 with a Phase 2 trial showing promise for an Alzheimer's therapeutic. Building on this success, GemVax has launched a Phase 2 pilot trial for PSP patients in Korea, with plans for international expansion. Their involvement in Neuro2024 represents a key milestone as they advance clinical trials with the goal of global commercialization. Learn more about our partners at Neuro2024 here: https://lnkd.in/ePGxJqm6    #PSP #CBD #MSA #Research #Discovery

💡We're thrilled to announce the recipients of our Pipeline Grants. These grants are awarded to researchers working on translational projects aimed at developing new therapeutics and biomarkers for PSP and CBD. These scientists are at the forefront of turning groundbreaking discoveries into potential treatments. Their work will help us move closer to preventing, treating, and curing these challenging diseases. Maura Malpetti - University of Cambridge Yang You - Mayo Clinic Peng Zhong - University of Nebraska Medical Center Learn more about their work: https://lnkd.in/gPgttWmt #CurePSP #CurePSPGrants #Research